By expenditures
| Name | Title | Type |
|---|---|---|
| Jay Katz | Executive Director | Auditee |
| Patricia McGowan | Partner | Auditee |
| Jonathan Fink | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 391021 | 2025 | 2026-03-10 | CLIFTONLARSONALLEN LLP | $1.79M |
| 362935 | 2024 | 2025-07-24 | Cliftonlarsonallen LLP | $1.74M |
| 303527 | 2023 | 2024-04-15 | Cliftonlarsonallen LLP | $1.65M |
| 34988 | 2022 | 2023-01-16 | Cohnreznick LLP | $1.65M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 391021 | 2025 | 2026-03-10 | 1177621 | 2025-005 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 391021 | 2025 | 2026-03-10 | 1177620 | 2025-005 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 391021 | 2025 | 2026-03-10 | 1177619 | 2025-004 | Material Weakness | Yes | E |
| 391021 | 2025 | 2026-03-10 | 1177618 | 2025-004 | Material Weakness | Yes | E |
| 391021 | 2025 | 2026-03-10 | 1177617 | 2025-003 | Material Weakness | Yes | E |
| 391021 | 2025 | 2026-03-10 | 1177616 | 2025-003 | Material Weakness | Yes | E |
| 391021 | 2025 | 2026-03-10 | 1177615 | 2025-002 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 391021 | 2025 | 2026-03-10 | 1177614 | 2025-002 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 391021 | 2025 | 2026-03-10 | 1177613 | 2025-001 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 391021 | 2025 | 2026-03-10 | 1177612 | 2025-001 | Material Weakness | Yes | Allowable Costs/Cost Principles |
| 362935 | 2024 | 2025-07-24 | 1148341 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 1148340 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 1148339 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 1148338 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 1148337 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 1148336 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 1148335 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 1148334 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 571899 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 571898 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 571897 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 571896 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 571895 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 571894 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 571893 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 571892 | 2024-001 | Significant Deficiency | Yes | C |
| 303527 | 2023 | 2024-04-15 | 969701 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969700 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969699 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969698 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393259 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393258 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393257 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393256 | 2023-001 | Significant Deficiency | - | N |